Josh Trent is a principal based in Washington, D.C. In this role, Josh develops and manages complex, multi-sector alliances and advises clients throughout the health care sector on federal health care policy and strategy. Josh specializes in public insurance under Medicare, Medicaid, and the Children’s Health Insurance Program, private health insurance, the 340B program, the Affordable Care Act.
Prior to joining Leavitt Partners, Josh served as Chief Health Counsel for Chairman Greg Walden of the Committee on Energy and Commerce of the U.S. House of Representatives. During his time at the committee, Josh played a key role in the passage of bipartisan legislation to combat the opioid crisis and led House staff in 2018 negotiations to reauthorize the Pandemic and All-Hazards Preparedness Act.
Josh was previously Deputy Chief Health Counsel for Chairman Walden as well as Deputy Chief Health Counsel and Professional Staff for Chairman Fred Upton at the Committee. In these roles, he helped secure historic funding extension for the Children’s Health Insurance Program (CHIP), led the development of policies improving Medicaid, helped develop policies strengthening Medicare Advantage and CHIP, led the Committee’s efforts on the 340B drug discount program, and helped develop The Comprehensive Addiction and Recovery Act of 2016 and the 21st Century Cures Act.
Josh also spent nearly five years as health care policy advisor for U.S. Senator Tom Coburn (R-OK), served as deputy director of the Office of Refugee Resettlement at the U.S. Department of Health and Human Services, and served in the White House Office of Presidential Personnel.
Josh received his bachelors of arts from Union University and received his masters degree from the University of Bath in Bath, England.